Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis
Anneka Tomlinson(St Bartholomew's Hospital), Andrea Cipriani(Oxford Health NHS Foundation Trust), Sanae Kishimoto(Kyoto University), Aran Tajika(Kyoto University), Sino Kikuchi(Kyoto University), Astrid Chevance(Délégation Paris 5), Hissei Imai(Kyoto University), Orestis Efthimiou(University of Bern), Toshi A. Furukawa(Kyoto University), Emma New(Oxford Health NHS Foundation Trust), Georgia Salanti(University of Bern), Yusuke Ogawa(Kyoto University), Sarah Mather(Oxford Health NHS Foundation Trust), Katharine Boaden(Oxford Health NHS Foundation Trust)
Cited by 31
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k